Related Experiment Video
Updated: Jun 26, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Bolus dose remifentanil and sufentanil blunting cardiovascular intubation responses in children: a randomized,
Xu Liao1, Quan-Yong Yang, Fu-Shan Xue
1Department of Anaesthesiology, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.
Insights
Remifentanil 2 mcg/kg abolished cardiovascular responses to intubation in children but caused more depression. Sufentanil 0.2 mcg/kg did not fully blunt these responses, showing less adverse cardiovascular effects.
Area of Science:
- Anesthesiology
- Pediatric Anesthesia
- Cardiovascular Pharmacology
Background:
- Cardiovascular responses to tracheal intubation can be significant in children.
- Opioid analgesics are commonly used to attenuate these responses during general anesthesia.
Purpose of the Study:
- To compare the efficacy of remifentanil and sufentanil in blunting the cardiovascular response to intubation in healthy pediatric patients.
- To evaluate the incidence of adverse cardiovascular events associated with each agent.
Main Methods:
- A randomized, double-blind study involving 105 children (ASA 1-2) undergoing elective surgery.
- Children received either remifentanil 2 mcg/kg (Group R) or sufentanil 0.2 mcg/kg (Group S) as a bolus.
- Blood pressure and heart rate were monitored from baseline through 5 minutes post-intubation.
Main Results:
- Remifentanil significantly decreased blood pressure and heart rate, while sufentanil caused significant increases compared to baseline.
- Both agents differed significantly in their effects on blood pressure and heart rate at intubation and peak changes.
- While increases in blood pressure/heart rate were similar, significant decreases (>30%) were more frequent with remifentanil.
Conclusions:
- Sufentanil 0.2 mcg/kg does not fully suppress the cardiovascular response to intubation in children when used with propofol.
- Remifentanil 2 mcg/kg effectively abolishes the intubation response but is associated with greater cardiovascular depression.
Background And Objective:
The present randomized controlled study was designed to compare the efficacy of remifentanil 2 microg kg(-1) and sufentanil 0.2 microg kg(-1) by bolus injection on the cardiovascular response to intubation in healthy children.
Methods:
One hundred and five children, ASA 1-2 and scheduled for elective plastic surgery under general anaesthesia, were randomly divided into one of two study groups to receive the following treatments in a double-blind manner: remifentanil 2 microg kg(-1) (group R) and sufentanil 0.2 microg kg(-1) (group S). Blood pressure and heart rate (HR) were recorded before anaesthesia induction (baseline values), immediately before intubation (postinduction values), at intubation and every minute for 5 min after intubation. The percentage changes in systolic blood pressure (SBP) and HR relative to baseline values were calculated. The incidences of SBP and HR percentage changes of more than 30% of baseline values during the observation were recorded.
Results:
As compared with baseline values, blood pressure and HR at intubation and their maximum values during the observation increased significantly in group S, but decreased significantly in group R. Blood pressure and HR at intubation and their maximum values during the observation were significantly different between the groups. There were significant differences between the groups in the percentage changes of SBP and HR relative to baseline values and their maximum percentage changes during the observation. The incidences of SBP and HR percentage increases of more than 30% of baseline values were not significantly different between the groups, but the incidences of SBP and HR percentage decreases of more than 30% of baseline values were significantly higher in group R than in group S.
Conclusion:
In combination with propofol for anaesthesia induction in children, sufentanil 0.2 microg kg(-1) by bolus injection fails to depress the cardiovascular intubation response. Remifentanil 2 microg kg(-1) by bolus injection can completely abolish the cardiovascular intubation response, but causes more adverse cardiovascular depression.
Related Concept Videos
Parenteral Anesthetics: Overview
Drug Dosing: Infants and Children
Depolarizing Blockers: Pharmocokinetics
Inhalational Anesthetics: Overview
Drug Delivery: Enteral Route
Drugs in...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence